Regis Technologies: University of Alabama drug discovery partnership

Biotech firm Regis Technologies has announced a partnership with University of Alabama researchers aimed at developing a kit to speed discovery of potential drug therapies from plant-based sources. The project is funded by an initial $250,000 USD grant from the National Institutes of Health (NIH) Small Business Technology Transfer program. The initial $250,000 award to the company allows the team to enhance the kit to become more customer-friendly and establish its commercial potential and feasibility.

“The ultimate goal is to develop a commercially viable kit that will speed up the process of finding drugs from natural samples​,” said Lukasz Ciesla, assistant professor of biological sciences at the university. “The partnership with Regis Technologies is crucial to expand access to this innovation so more novel therapies can be discovered and begin the pipeline from the lab to patients​.”